Hirokawa Fumitoshi, Hayashi Michihiro, Asakuma Mitsuhiro, Shimizu Tetsunosuke, Inoue Yoshihiro, Uchiyama Kazuhisa
Department of General and Gastroenterological Surgery, Osaka Medical College, Japan.
Department of General and Gastroenterological Surgery, Osaka Medical College, Japan.
Surg Oncol. 2016 Mar;25(1):24-9. doi: 10.1016/j.suronc.2015.12.002. Epub 2015 Dec 12.
Hepatocellular carcinoma (HCC) often recurs after curative hepatectomy; and early recurrence after hepatectomy (ERAH) is associated with poor prognosis. This study aimed to clarify risk factors and disease patterns for ERAH.
We retrospectively analyzed clinicopathological factors of 232 patients who underwent initial curative hepatectomies for HCC between April 2000 and March 2013, and examined associated risk factors and early recurrence patterns by liver function status (as indicated by indocyanine green retention rate at 15 min [ICGR15]).
Patients who experienced recurrence within 6 months after hepatectomy (i.e., ERAH) had significantly shorter survival than those with longer disease-free intervals (P < 0.001). In multivariate analysis, microvascular invasion (mVI; P = 0.034) and ICGR15 ≥ 16% (P = 0.010) were independent risk factors for ERAH. In the ICGR1<16% subgroup, positive L3-AFP (P = 0.04), tumor size ≥ 5 cm (P = 0.011), surgical margin = 0 (P = 0.0103), mVI (P = 0.034), and extrahepatic recurrence were significant predictors of ERAH; in the ICGR15 ≥ 16%, subgroup, multiple tumors (P = 0.046) were identified as a risk factor for ERAH; however, this group did not experience much extrahepatic recurrence.
ERAH was associated with mVI and ICGR15 ≥ 16%. Recurrence patterns and risk factors vary by liver function status, which should be considered in forming management strategies for early recurrence of HCC after curative hepatectomy.
肝细胞癌(HCC)在根治性肝切除术后常复发;肝切除术后早期复发(ERAH)与预后不良相关。本研究旨在明确ERAH的危险因素和疾病模式。
我们回顾性分析了2000年4月至2013年3月期间因HCC接受初次根治性肝切除术的232例患者的临床病理因素,并根据肝功能状态(以15分钟吲哚菁绿潴留率[ICGR15]表示)检查相关危险因素和早期复发模式。
肝切除术后6个月内复发(即ERAH)的患者生存期明显短于无病间期较长的患者(P<0.001)。多因素分析显示,微血管侵犯(mVI;P = 0.034)和ICGR15≥16%(P = 0.010)是ERAH的独立危险因素。在ICGR1<16%亚组中,L3-AFP阳性(P = 0.04)、肿瘤大小≥5 cm(P = 0.011)、手术切缘= 0(P = 0.0103)、mVI(P = 0.034)和肝外复发是ERAH的显著预测因素;在ICGR15≥16%亚组中,多发肿瘤(P = 0.046)被确定为ERAH的危险因素;然而,该组肝外复发较少。
ERAH与mVI和ICGR15≥16%相关。复发模式和危险因素因肝功能状态而异,在制定根治性肝切除术后HCC早期复发的管理策略时应予以考虑。